Serial Number
50015725
Owner
Cogent Biosciences, Inc.Attorney
Gabriel M. GillmeyerFiling Date
Jul 27, 2026
COGENT CONNECT Trademark
Serial Number: 50015725
Trademark Classes
Class 36 - Insurance & Financial
Insurance; financial affairs; monetary affairs; real estate affairs
Class 41 - Education & Entertainment
Education; providing of training; entertainment; sporting and cultural activities
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Class 45 - Legal & Security Services
Legal services; security services for the protection of property and individuals
Class 35 - Advertising & Business
Advertising; business management; business administration; office functions
Owner Contact Info
275 Wyman Street, 3rd Floor
Waltham, MA 02451
Entity Type: 03
Legal Representation
Correspondence Address
Gabriel M. Gillmeyer Ropes & Gray LLP
Prudential Tower, 800 Boylston Street
Boston, MA 02199
United States
Trademark Details
Filing Date
July 27, 2026
Registration Date
Not Registered
Goods & Services
Educational services, namely, conducting patient education programs in the field of disease management
Providing a website featuring educational information, namely, information for patients relating to cancer and rare genetic diseases and their prescribed medication; Providing a website featuring educational information regarding therapeutic properties of pharmaceutical products to patients relating to cancer and rare diseases; Providing educational information about healthcare; Healthcare services, namely, disease management programs; Prescription refill reminder services
Providing case management services, namely, coordinating medical services and medication programs for patients with cancer and rare genetic diseases
Financial administration of medication reimbursement programs and services; Providing insurance information in the field of health insurance and health insurance reimbursement; Administration of financial assistance and reimbursement programs, namely, administration of financial assistance and reimbursement programs that enable patients to more affordably access prescription drugs for the treatment of cancer and rare genetic diseases
Business administration of medication reimbursement programs and services